newsfilter
← Latest News
PR Newswire·

Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology

INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and DICE Therapeutics, Inc. (NASDAQ:DICE) today announced a definitive agreement for Lilly to acquire